tiprankstipranks
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
India Market
GLAXO
GlaxoSmithKline Pharmaceuticals Limited
RESEARCH TOOLSreports

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Income Statement

7 Followers

GlaxoSmithKline Pharmaceuticals Limited Income Statement

Last quarter (Q2 2026), GlaxoSmithKline Pharmaceuticals Limited's total revenue was ₹9.80B, a decrease of -3.05% from the same quarter last year. In Q2, GlaxoSmithKline Pharmaceuticals Limited's net income was ₹2.57B. See GlaxoSmithKline Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 37.26B₹ 34.42B₹ 32.26B₹ 32.64B₹ 28.99B
Gross Profit
₹ 22.53B₹ 20.22B₹ 18.68B₹ 18.14B₹ 15.61B
Operating Expenses
₹ 11.39B₹ 11.83B₹ 11.19B₹ 11.16B₹ 10.41B
Depreciation and Amortization
₹ 666.58M₹ 695.36M₹ 656.23M₹ 680.42M₹ 784.61M
EBITDA
₹ 13.28B₹ 8.88B₹ 9.04B₹ 8.49B₹ 5.36B
Operating Income
₹ 11.14B₹ 8.38B₹ 7.48B₹ 6.99B₹ 5.20B
Other Income/Expenses
₹ 1.46B₹ -222.98M₹ 879.74M₹ 748.15M₹ -656.04M
Pretax Income
₹ 12.60B₹ 8.16B₹ 8.36B₹ 7.79B₹ 4.54B
Net Income
₹ 9.28B₹ 5.90B₹ 6.11B₹ 16.95B₹ 3.58B
Per Share Metrics
Basic EPS
₹ 54.76₹ 34.83₹ 35.87₹ 100.04₹ 21.14
Diluted EPS
₹ 54.76₹ 34.83₹ 35.87₹ 100.04₹ 21.14
Weighted Average Shares Outstanding
 169.41M 169.41M 170.25M 178.98M 169.41M
Weighted Average Shares Outstanding (Diluted)
 169.41M 169.41M 169.41M 169.41M 169.41M
Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History